IN-DATE
U813036: Bard Ultraverse 018 PTA Balloon Dilatation Catheter: 3mm x 60mm x 130cm
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $159.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Expiration: | 04-2027 |
| Express: | Need it tomorrow? Order in next 10 hours 38 minutes and choose overnight shipping at checkout. |
Additional Details
Bard Ultraverse 018 PTA Balloon Dilatation Catheter
- Advanced innovation for exceptional performance
- Ultra-Cross dual layer hydrophilic coating and Checker Flex Points for optimal performance in distal peripheral anatomies.
- Superior Pushability – Innovative, reinforced inner lumen promotes improved axial strength for crossing tight lesions.
AccessGUDID Info
- FDA Product Code: LIT
- FDA Product Code Name: Catheter, angioplasty, peripheral, transluminal
- GMDN Term Code: 17184
- GMDN Term Name: Peripheral angioplasty balloon catheter, basic
- GMDN Term Description: A sterile, non-drug-eluting, flexible tube designed for percutaneous transluminal angioplasty (PTA) to dilate a stenotic peripheral (i.e., non-cerebral, non-coronary) artery by controlled inflation of a distensible balloon(s) at its distal tip; it may also be intended for positioning and expansion of a stent/stent-graft. It is available as an over-the-wire (OTW) type with multiple lumens, or a rapid exchange (RX) type with a single lumen. Some types may include cutting/scoring elements (e.g., microsurgical blades, dual wire configurations) to score/modify the plaque. This is a single-use device.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
